Journal of Clinical Oncology, Vol 13, 1255-1264, Copyright © 1995 by American Society of Clinical Oncology

ARTICLES

Someone to live for: social well-being, parenthood status, and decision- making in oncology

SB Yellen and DF Cella
Department of Psychology and Social Sciences, Rush-Presbyterian-St Luke's Medical Center, Chicago, IL, USA.

PURPOSE: Little is known about the influence of social factors on treatment preferences and desire for aggressive cancer therapy. The present study assessed subjective and objective social indicators in patient preferences for treatment. METHODS: Cancer patients (N = 296) with diverse diagnoses and stages read sets of hypothetical vignettes describing patients with early-stage and advanced disease. In the first set, patients made decisions about treatment acceptance given varying levels of either increasing cure or extending survival. In the second set, the point at which patients shifted preferences from mild to severe treatment to improve likelihood of 1-year survival (switch point) was the dependent measure. We assessed the impact of quality-of- life (QL) domains measured by the Functional Assessment of Cancer Therapy-General (FACT-G), having children, marital status, and living arrangements on treatment preferences and switch points. RESULTS: The Social Well-Being (SWB) subscale of the FACT-G predicted both treatment acceptance (P = .007) and switch point (P = .043) in the advanced- disease vignettes, with lower SWB associated with less aggressive preferences. Children living at home was likewise associated with more aggressive intent both in treatment preferences (P = .003, advanced- disease vignette) and switch point (P < .001 and P = .001 for early- and advanced-disease vignettes, respectively). Living with others predicted more aggressive intent in the advanced-disease vignette (P = .03). Marital status did not predict either treatment acceptance or switch point. CONCLUSION: Positive social well-being, as well as having children living at home, predicted patient willingness to accept aggressive treatment. Willingness to receive aggressive treatment may explain or mediate previously reported salutory effects of social support on cancer outcomes.

This article has been cited by other articles:

				J. J. van Tol-Geerdink, P. F.M. Stalmeier, E. N.J.T. van Lin, E. C. Schimmel, H. Huizenga, W. A.J. van Daal, and J.-W. Leer Do Patients With Localized Prostate Cancer Treatment Really Want More Aggressive Treatment? J. Clin. Oncol., October 1, 2006; 24(28): 4581 - 4586. [Abstract] [Full Text] [PDF]

				R. Matsuyama, S. Reddy, and T. J. Smith Why Do Patients Choose Chemotherapy Near the End of Life? A Review of the Perspective of Those Facing Death From Cancer J. Clin. Oncol., July 20, 2006; 24(21): 3490 - 3496. [Abstract] [Full Text] [PDF]

				V. M. Duric, M. R. Stockler, S. Heritier, F. Boyle, J. Beith, A. Sullivan, N. Wilcken, A. S. Coates, and R. J. Simes Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now? Ann. Onc., November 1, 2005; 16(11): 1786 - 1794. [Abstract] [Full Text] [PDF]

				D. Cella, C.-H. Chang, B. D. Wright, J. H. Von Roenn, and R. T. Skeel Defining Higher Order Dimensions of Self-Reported Health: Further Evidence for a Two-Dimensional Structure Eval Health Prof, June 1, 2005; 28(2): 122 - 141. [Abstract] [PDF]

				S. J.T. Jansen, W. Otten, and A. M. Stiggelbout Review of Determinants of Patients' Preferences for Adjuvant Therapy in Cancer J. Clin. Oncol., August 1, 2004; 22(15): 3181 - 3190. [Abstract] [Full Text] [PDF]

				T. D. Shanafelt, C. Loprinzi, R. Marks, P. Novotny, and J. Sloan Are Chemotherapy Response Rates Related to Treatment-Induced Survival Prolongations in Patients With Advanced Cancer? J. Clin. Oncol., May 15, 2004; 22(10): 1966 - 1974. [Abstract] [Full Text] [PDF]

				E. J. Emanuel, Y. Young-Xu, N. G. Levinsky, G. Gazelle, O. Saynina, and A. S. Ash Chemotherapy Use among Medicare Beneficiaries at the End of Life Ann Intern Med, April 15, 2003; 138(8): 639 - 643. [Abstract] [Full Text] [PDF]

				B. Koczwara and M. M. Clark A Couple With Cancer: Conflicting Wishes, Joint Decisions J. Clin. Oncol., January 1, 2003; 21(1): 174 - 176. [Full Text] [PDF]

				C.G. Koedoot, J.C.J.M. de Haes, S.H. Heisterkamp, P.J.M. Bakker, A. de Graeff, and R.J. de Haan Palliative Chemotherapy or Watchful Waiting? A Vignettes Study Among Oncologists J. Clin. Oncol., September 1, 2002; 20(17): 3658 - 3664. [Abstract] [Full Text] [PDF]

				T. A. Abend and G. M. Williamson Feeling Attractive in the Wake of Breast Cancer: Optimism Matters, and So Do Interpersonal Relationships Pers Soc Psychol Bull, April 1, 2002; 28(4): 427 - 436. [Abstract] [PDF]

				S. J. Lee, A. L. Back, S. D. Block, and S. K. Stewart Enhancing Physician-Patient Communication Hematology, January 1, 2002; 2002(1): 464 - 483. [Abstract] [Full Text]

				D. Schrag, S. E. Gelfand, P. B. Bach, J. Guillem, B. D. Minsky, and C. B. Begg Who Gets Adjuvant Treatment for Stage II and III Rectal Cancer? Insight From Surveillance, Epidemiology, and End Results-Medicare J. Clin. Oncol., September 1, 2001; 19(17): 3712 - 3718. [Abstract] [Full Text] [PDF]

				D. Schrag, L. D. Cramer, P. B. Bach, and C. B. Begg Age and Adjuvant Chemotherapy Use After Surgery for Stage III Colon Cancer J Natl Cancer Inst, June 6, 2001; 93(11): 850 - 857. [Abstract] [Full Text] [PDF]

				A. M. Stiggelbout and J. C.J.M. de Haes Patient Preference for Cancer Therapy: An Overview of Measurement Approaches J. Clin. Oncol., January 1, 2001; 19(1): 220 - 230. [Abstract] [Full Text] [PDF]

				P. A. Bunn Jr, J. Mault, and K. Kelly Adjuvant and Neoadjuvant Chemotherapy for Non-Small Cell Lung Cancer : A Time for Reassessment? Chest, April 1, 2000; 117(4_suppl_1): 119S - 122S. [Abstract] [Full Text] [PDF]

				J. D. Cheng, J. Hitt, B. Koczwara, K. A. Schulman, C. B. Burnett, D. J. Gaskin, J. H. Rowland, and N. J. Meropol Impact of Quality of Life on Patient Expectations Regarding Phase I Clinical Trials J. Clin. Oncol., January 14, 2000; 18(2): 421 - 421. [Abstract] [Full Text] [PDF]

				N. M. Ellison Palliative chemotherapy American Journal of Hospice and Palliative Medicine, March 1, 1998; 15(2): 93 - 103. [PDF]

				D. J. Gaskin, J. Kong, N. J. Meropol, K. R. Yabroff, C. Weaver, and K. A. Schulman Treatment Choices by Seriously III Patients: The Health Stock Risk Adjustment Model Med Decis Making, January 1, 1998; 18(1): 84 - 94. [Abstract] [PDF]

				M. Ersek, B. R. Ferrell, K. H. Dow, and C. H. Melancon Quality of Life in Women with Ovarian Cancer West J Nurs Res, June 1, 1997; 19(3): 334 - 350. [Abstract] [PDF]